Skip to main content
. 2019 May 24;28(6):1779–1784. doi: 10.1007/s10068-019-00627-3

Table 1.

Mean symptoms sum-score (± SD) of all symptoms, 10 GI symptoms, the 5 most diagnostic GI symptoms, 4 cardiovascular symptoms, 4 respiratory symptoms and 4 skin complaints during the study period of 8 weeks

Symptoms 4 weeks of DAO supplementation 4 weeks without DAO
Visit 1
Mean (± SD)
Visit 2
Mean (± SD)
Visit 3
Mean (± SD)
Visit 4
Mean (± SD)
Visit 5
Mean (± SD)
All symptoms 19.6 (± 9.9) 10.6 (± 7.7) 6.6 (± 6.4) p < 0.0001 10 (± 8.3) 12.5 (± 9) p = 0.002
GI 11.2 (± 7.5) 6.1 (± 5.2) 3.8 (± 4.4) p < 0.0001 6.5 (± 5.9) 7.1 (± 5.3) p = 0.0058
Diagnostic GI 8.4 (± 5.6) 4.8 (± 4.1) 3.1 (± 3.4) p < 0.0001 5 (± 5) 5.4 (± 4.3) p = 0.0312
Cardiovascular 3.6 (± 2.8) 1.9 (± 2.1) 1 (± 1.2) p < 0.0001 1.3 (± 1.7) 1.8 (± 2.2) p = 0.0783
Respiratory 2.4 (± 2.7) 1.6 (± 2) 1.2 (± 1.6) p < 0.0001 1.2 (± 1.7) 2.4 (± 2.6) p = 0.0029
Skin 2.4 (± 3.1) 1 (± 1.5) 0.5 (± 1) p < 0.0001 0.9 (± 1.6) 1.2 (± 2.2) p = 0.1289

The significance of the change in symptoms over time was calculated using the Friedman test

DAO diamine oxidase, GI Gastrointestinal